Ravindra Kamble

Dr. Ravindra Kamble


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2015 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
RKRavindra Kamble
Ravindra Kamble
PMPiyush Pradeep Mehta
Piyush Pradeep Mehta
AKAjay Kumar
Ajay Kumar

9 April 2021 in Particulate Science and Technology
Verified
Journal Article
Closed access
KPKhushboo Patel
Khushboo Patel
CBChellampillai Bothiraja
Chellampillai Bothiraja
AMAshwin Mali
Ashwin Mali
RKRavindra Kamble
Ravindra Kamble
The present hypothesis was to identify the potential of sorafenib tosylate (ST) loaded liposomal dry powder inhaler (ST-LDPI) for targeting non-small cell lung cancer (NSCLC). ST-LDPI was obtained by spray drying the ST loaded liposomes, evaluated for physicochemical properties and in vitro lung deposition by Andersen Cascade Impactor (ACI). Optimized liposomal formulation showed the particle size, zeta potential, encapsulation efficiency and drug content of 111.15 ± 1.03 nm, −29.87 ± 0.56 mV, 93.13 ± 1.11% and 84.47 ± 1.28%, respectively. Furthermore, ST-LDPI exhibited low density and good flowability. FESEM confirmed the spherical nature of particles with mean size of 3.15 ± 0.51 μm. The DSC and FTIR spectra revealed complete encapsulation of ST. Further, the PXRD showed reduced crystallinity ST. In vitro deposition demonstrated the fine particle fraction of 83.7 ± 0.09%, recovery of 95.43 ± 0.03%, mean mass aerodynamic diameter 3.15 ± 0.2 µm, geometric standard deviation 1.78 ± 0.15 µm and 85 ± 0.1% dispersibility. The In vitro drug release revealed biphasic release pattern, burst release in the first 6 h followed by sustained release up to 72 h. Hence this novel approach could be a targeted delivery of ST to the NSCLC treatment.

16 April 2019 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
RKRavindra Kamble
Ravindra Kamble
RMR. V. Mehtre
R. V. Mehtre
PMPiyush Pradeep Mehta
Piyush Pradeep Mehta
PNP. Nangare
P. Nangare
SPS. S. Patil
S. S. Patil

14 July 2017 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Closed access
PDF file
RKRavindra Kamble
Ravindra Kamble
BCBothiraja Chellampillai
Bothiraja Chellampillai
PMPiyush Pradeep Mehta
Piyush Pradeep Mehta
VVV. Varghese
V. Varghese

1 January 2018 in Journal of King Saud University – Science
Verified
Journal Article
Open access
SPSharvil Patil
Sharvil Patil
KCKhushbu Chaudhari
Khushbu Chaudhari
RKRavindra Kamble
Ravindra Kamble
Poor aqueous solubility of most of the phytomolecules has restricted their vital biological use. Cocrystal approach can be one of the remedies for the problem. The present work was carried out with an objective to screen the potential of electrospray technique towards cocrystallization of quercetin (QUE). QUE was cocrystallized with caffeine (CAF) and nicotinamide (NIC) as coformers. Saturated methanolic solutions of QUE with either of the coformers (CAF and NIC) in 1:1 ratio were electrosprayed at 40 °C. The technique was successfully used for cocrystallization of QUE with CAF and NIC separately as revealed by Powder X-ray Diffraction, Differential scanning calorimetry and Fourier transform infrared spectroscopy studies. Additionally, the results of saturation solubility study suggested 14 and 11 folds increase in solubility of QUE upon its cocrystallization with CAF and NIC respectively. Herein we propose a new technique for cocrystallization and in turn resolving solubility issues of phytomolecules which can be an alternative to the existing cocrystallisation techniques

3 December 2020 in Materials Technology
Verified
Journal Article
Closed access
CBC. Bothiraja
C. Bothiraja
KDKartiki Dhage
Kartiki Dhage
RKRavindra Kamble
Ravindra Kamble
Olanzapine (OLA), a first atypical antipsychotic moleculethat experiences low brain permeability because of efflux by P-glycoproteins (Pgp) in the brain and extensive hepatic first-pass metabolism. The present investigation intended to design OLA-loaded mixed micelles (MM) and study their nose-to-brain targeting capability. OLA-MM was prepared by a mixture of d-α-tocopheryl polyethylene glycol 1000 succinate and gelucire®44/14 (stearoylmacrogol glycerides) (OLA-TPGL-MM) using the solvent evaporation technique. OLA-TPGL-MM was studied for various physiochemical properties, in-vitro release, ex-vivodrug permeation and in-vivo pharmacokinetic potential in male Wister rats as compared to OLA alone. Developed OLA-TPGL-MM showed particle size, negative zeta potential and entrapment efficiency of 125 nm, −5.97 mV and > 83%, respectively. OLA-TPGL-MM showed 2.12 and 1.85-fold improvement in in-vitro and ex-vivo OLA release and permeation. Substantially higher values for intranasal (i.n) OLA-TPGL-MM in drug targeting efficiency (265.36%), drug targeting index (1.82) and direct transport percentage (64.36%) indicating the potential of non-invasive OLA-loaded MM nose-to-brain targeting delivery system. TheTPGS and gelucire®44/14 based MM has a great potential for the safe and effective delivery of antipsychotic molecules in the treatment of CNS disorders. GRAPHICAL ABSTRACT